Juraj Kavecansky, MD
Medical Oncology Physician · Walnut Creek, CA
Juraj Kavecansky, MD is a medical oncology physician with a practice address in Walnut Creek, California, and NPI 1942592563, issued on May 16, 2011. Check the license (California A148318, as entered in NPPES) on the Medical Board of California; the Medicare figures below come from public CMS files.
- Name
- Juraj Kavecansky
- Credential
- MD
- Primary taxonomy
- Medical Oncology Physician 207RX0202X
- License numbers
- A148318 CA
DR.0077225 CO
Self-reported in NPPES; status is on the state search - Practice location
- 1425 S Main St FL 2, Walnut Creek, CA 94596
- Phone
- (925) 295-4030
- Enumerated
- May 16, 2011
- Record last updated
- Apr 1, 2026
- Medicare enrollment
- Enrolled (PECOS I20170907002721); accepts Medicare assignment
- Entity
- Type 1 · individual
8 nearest medical oncology physician records → All 447 in California → Look up another NPI →
Also registered at 1425 S Main St FL 2
A shared address usually means a shared clinic or building; it does not show who employs whom.
- Brandon Davalle, D.O.General Practice Physician1528122330
- Kevin Ng, M.D.Anesthesiology Physician1154394765
Verify Juraj Kavecansky in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersMedical Board of California
Search for license A148318Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
51% more Medicare Part D claims than the average medical oncology physician in 2024
1,062 Medicare Part D claims for 197 beneficiaries, against an average of 703 among the 4,230 providers of this specialty who prescribed in Part D. 124 claims were for opioids.
Most prescribed
- Hydroxyurea97 claims
- Lenalidomide74 claims
- Hydrocodone-Acetaminophen60 claims
- Ondansetron Hcl40 claims
- Dexamethasone38 claims
- Pomalyst34 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
Industry payments in 2024: $14.98
1 payment: food and beverage; the largest payer was Recordati_rare_diseases_inc. The 3,343 providers of this specialty with any payment received $11,773.47 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.
Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.
Bills Medicare through one group practice
- Permanente Medical Group IncRichmond, CA
Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).
Juraj Kavecansky among 447 medical oncology physician records in California
Juraj Kavecansky, MD is one of 447 medical oncology physician records with a practice address in California. 82% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2011, is newer than 67% of them.
- NPI issued2011 · 67% of these records are older, 28% newer
- In a Medicare fileYes · 82% of these records are
- In the CMS Doctors and Clinicians fileYes · 70% of these records are
- Graduated2002 · median 2004 among the 312 with a school on file
- Record last updated2026 · 41% of these records were not updated in five years or more
Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 207RX0202X and a California practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).
Medical Oncology Physician providers in California
There are 447 medical oncology physician records in California.
All 447 in California → Every provider in Walnut Creek → Medical Oncology Physician nationwide →
The 8 medical oncology physician records with the nearest ZIP codes
- Ethan Schram, M.D.Walnut Creek, CA 945981659320703
- Shihfan Yeh, M.D.Vallejo, CA 945891013145556
- Abinav Baweja, MDPleasanton, CA 945881770961575
- Barbara Egan, M.D.Pleasanton, CA 945881154418622
- Ruby Maini, MDPleasanton, CA 945881063906063
- Kavitha Raj, MDPleasanton, CA 945881053450767
- Rishi Sawhney, M.D.Pleasanton, CA 945881881812519
- Thomas Yang Sun, MDPleasanton, CA 945881215468160
Common questions
What is Juraj Kavecansky, MD's NPI number?
Juraj Kavecansky, MD's National Provider Identifier (NPI) is 1942592563, issued on May 16, 2011. An NPI identifies a provider in billing; it is not a license.
Where is Juraj Kavecansky, MD located?
The NPPES record lists a practice address at 1425 S Main St FL 2, Walnut Creek, CA, 94596. Phone: (925) 295-4030. Providers update this record themselves, so call before visiting.
How can I verify Juraj Kavecansky, MD's license?
NPPES lists California license number A148318, as entered by the provider. Search the Medical Board of California at https://www.mbc.ca.gov/License-Verification/default.aspx. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Juraj Kavecansky, MD prescribe under Medicare Part D?
In 2024, Juraj Kavecansky, MD had 1,062 Medicare Part D claims for 197 beneficiaries; the average among medical oncology physician prescribers was 703. Part D covers Medicare prescriptions only.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.